https://qlinea.com/us/ 2025-03-28T12:22:02+00:00 https://qlinea.com/us/annual-general-meeting-2026/ 2026-06-03T13:41:32+00:00 https://qlinea.com/us/cybersecurity/ 2025-10-21T07:15:47+00:00 https://qlinea.com/us/podler/ 2025-09-18T11:23:54+00:00 https://qlinea.com/us/annual-general-meeting-2025/ 2025-05-23T12:27:24+00:00 https://qlinea.com/us/extraordinary-general-meeting-2025/ 2026-02-12T11:02:30+00:00 https://qlinea.com/us/sources/ 2024-09-16T15:54:36+00:00 https://qlinea.com/us/antimicrobial-resistance/ 2024-07-08T13:02:08+00:00 https://qlinea.com/us/astar-for-clinicians/ 2025-02-01T15:23:18+00:00 https://qlinea.com/us/words-about-us/presentation-stephen-p-kidd/ 2023-10-10T11:34:58+00:00 https://qlinea.com/us/important-information/ 2023-06-12T07:31:07+00:00 https://qlinea.com/us/extraordinary-general-meeting-2023/ 2023-06-05T15:54:10+00:00 https://qlinea.com/us/annual-general-meeting-2023/ 2023-04-21T12:42:30+00:00 https://qlinea.com/us/distributor-portal/ 2023-03-27T06:35:39+00:00 https://qlinea.com/us/distributors/ 2026-05-29T09:41:02+00:00 https://qlinea.com/us/annual-general-meeting-2022/ 2022-04-25T09:48:53+00:00 https://qlinea.com/us/code-of-conduct/ 2022-03-28T13:56:22+00:00 https://qlinea.com/us/customer-portal/settings/ 2021-11-12T12:39:25+00:00 https://qlinea.com/us/login/ 2023-11-17T13:16:33+00:00 https://qlinea.com/us/customer-portal/ 2024-07-03T12:08:22+00:00 https://qlinea.com/us/annual-general-meeting-2021/ 2021-04-22T08:19:00+00:00 https://qlinea.com/us/third-party-licenses/ 2025-08-18T11:24:56+00:00 https://qlinea.com/us/d41d7c41a238cd674bb30ea96a818f14/ 2021-04-21T06:47:47+00:00 https://qlinea.com/us/request-product-documents/ 2021-04-21T05:59:58+00:00 https://qlinea.com/us/request-consultation/ 2024-02-28T12:23:33+00:00 https://qlinea.com/us/support-zone/ 2025-01-28T08:07:22+00:00 https://qlinea.com/us/webinar-11-10/ 2020-11-11T10:14:04+00:00 https://qlinea.com/us/webinar-10-11-2020/ 2020-10-12T13:49:14+00:00 https://qlinea.com/us/patents/ 2024-09-18T13:56:42+00:00 https://qlinea.com/us/investor-relations/press-releases/ 2020-05-26T06:56:12+00:00 https://qlinea.com/us/contact-and-media/locations-and-directions/ 2026-06-10T07:43:45+00:00 https://qlinea.com/us/investor-relations/financial-calendar/ 2026-06-22T12:23:16+00:00 https://qlinea.com/us/examples/ 2020-05-15T06:10:16+00:00 https://qlinea.com/us/webinar-03-06-2020/ 2020-05-14T13:26:31+00:00 https://qlinea.com/us/annual-general-meeting-2020/ 2020-04-24T07:19:32+00:00 https://qlinea.com/us/webinar-registration/ 2020-03-13T07:01:56+00:00 https://qlinea.com/us/q-linea-intends-to-list-its-shares-on-nasdaq-stockholm/ 2020-01-17T12:51:35+00:00 https://qlinea.com/us/stabilization-notice-and-end-of-the-stabilization-period/ 2020-01-17T12:49:36+00:00 https://qlinea.com/us/stabilization-notice/ 2020-01-17T12:48:16+00:00 https://qlinea.com/us/trading-in-q-lineas-share-commences-tomorrow-on-nasdaq-stockholm/ 2020-01-17T12:47:09+00:00 https://qlinea.com/us/q-linea-publishes-prospectus-for-initial-public-offering-on-nasdaq/ 2020-01-17T12:46:14+00:00 https://qlinea.com/us/extraordinary-general-meeting-2018/ 2020-01-15T10:20:21+00:00 https://qlinea.com/us/annual-general-meeting-2019/ 2020-01-15T09:28:14+00:00 https://qlinea.com/us/ceo-comment/ 2026-06-11T13:36:40+00:00 https://qlinea.com/us/privacy-policy/ 2024-03-18T07:39:32+00:00 https://qlinea.com/us/contact-and-media/contact/ 2019-12-19T10:50:21+00:00 https://qlinea.com/us/investor-relations/the-share/share-capital-development/ 2019-12-19T10:49:45+00:00 https://qlinea.com/us/mission-vision/ 2019-12-19T10:46:58+00:00 https://qlinea.com/us/astar-in-the-lab/astar-kits/ 2026-04-28T08:13:13+00:00 https://qlinea.com/us/astar-in-the-lab/astar/ 2019-12-19T10:43:44+00:00 https://qlinea.com/us/investor-relations/ipo/contacts/ 2019-12-19T08:47:01+00:00 https://qlinea.com/us/investor-relations/ipo/key-dates/ 2019-12-19T08:46:51+00:00 https://qlinea.com/us/investor-relations/ipo/prospectus/ 2019-12-19T08:46:39+00:00 https://qlinea.com/us/investor-relations/ipo/press-releases-about-ipo/ 2019-12-19T08:46:29+00:00 https://qlinea.com/us/investor-relations/ipo/about-the-ipo/ 2019-12-19T08:46:15+00:00 https://qlinea.com/us/investor-relations/corporate-governance/articles-of-association/ 2025-08-11T07:54:35+00:00 https://qlinea.com/us/investor-relations/corporate-governance/audit/ 2026-06-02T06:34:16+00:00 https://qlinea.com/us/investor-relations/corporate-governance/internal-audit-and-control/ 2019-12-19T08:45:13+00:00 https://qlinea.com/us/investor-relations/corporate-governance/management/renumeration-to-president-and-management-team/ 2026-01-08T08:02:25+00:00 https://qlinea.com/us/investor-relations/corporate-governance/management/ 2026-06-26T07:21:30+00:00 https://qlinea.com/us/investor-relations/corporate-governance/board-of-directors/board-committees/ 2025-08-27T06:44:02+00:00 https://qlinea.com/us/investor-relations/corporate-governance/board-of-directors/board-procedures/ 2019-12-19T08:42:34+00:00 https://qlinea.com/us/investor-relations/corporate-governance/board-of-directors/remuneration-to-the-board-of-directors/ 2025-08-27T06:50:13+00:00 https://qlinea.com/us/investor-relations/corporate-governance/board-of-directors/the-boards-duties/ 2026-06-02T06:42:43+00:00 https://qlinea.com/us/investor-relations/corporate-governance/board-of-directors/ 2026-06-26T07:29:48+00:00 https://qlinea.com/us/investor-relations/corporate-governance/nomination-committee/ 2026-06-02T07:07:23+00:00 https://qlinea.com/us/investor-relations/corporate-governance/general-meeting/general-meetings/ 2026-06-18T11:44:24+00:00 https://qlinea.com/us/investor-relations/corporate-governance/general-meeting/ 2019-12-19T08:40:35+00:00 https://qlinea.com/us/investor-relations/the-share/ownership-structure/ 2019-12-19T08:39:39+00:00 https://qlinea.com/us/investor-relations/the-share/trading-information/ 2026-06-10T07:44:24+00:00 https://qlinea.com/us/contact-and-media/subscribe/ 2019-12-19T07:08:45+00:00 https://qlinea.com/us/investor-relations/ipo/ 2026-06-22T12:32:08+00:00 https://qlinea.com/us/investor-relations/corporate-governance/ 2019-12-04T14:59:20+00:00 https://qlinea.com/us/investor-relations/reports-and-presentations/ 2026-05-22T10:21:08+00:00 https://qlinea.com/us/investor-relations/the-share/ 2026-06-18T11:23:21+00:00 https://qlinea.com/us/contact-and-media/image-bank/ 2019-12-04T13:58:24+00:00 https://qlinea.com/us/resources/ 2026-06-29T06:51:45+00:00 https://qlinea.com/us/business-concept-and-strategy/ 2025-03-19T08:09:07+00:00 https://qlinea.com/us/about-us/news-and-events/ 2025-01-10T10:54:30+00:00 https://qlinea.com/us/words-about-us/ 2025-01-10T11:24:49+00:00 https://qlinea.com/us/research/ 2019-12-04T13:56:35+00:00 https://qlinea.com/us/astar-in-the-lab/sepsis/ 2024-07-08T13:04:41+00:00 https://qlinea.com/us/astar-in-the-lab/astar/astar-instrument/ 2019-12-04T10:25:32+00:00 https://qlinea.com/us/about-us/ 2024-07-08T12:57:13+00:00 https://qlinea.com/us/contact-and-media/ 2026-06-26T07:26:22+00:00 https://qlinea.com/us/investor-relations/ 2026-06-26T07:24:18+00:00 https://qlinea.com/us/astar-in-the-lab/ 2025-03-21T14:46:16+00:00 https://qlinea.com/us/mfn_news/annika-blondeau-henriksson-new-interim-cfo/ 2026-05-29T11:25:28+00:00 https://qlinea.com/us/mfn_news/bulletin-from-annual-general-meeting-in-q-linea-ab-publ-8/ 2026-05-28T08:11:07+00:00 https://qlinea.com/us/mfn_news/interim-report-january-march-2026/ 2026-05-06T06:27:30+00:00 https://qlinea.com/us/mfn_news/notice-of-annual-general-meeting-in-q-linea-ab-publ-8/ 2026-04-27T17:05:00+00:00 https://qlinea.com/us/mfn_news/q-linea-publish-the-annual-report-for-2025/ 2026-04-24T06:48:46+00:00 https://qlinea.com/us/mfn_news/q-linea-announces-fda-clearance-of-expanded-astar-blood-testing-menu/ 2026-04-22T08:58:54+00:00 https://qlinea.com/us/mfn_news/q-linea-announces-shipment-of-two-astar-instruments-to-saudi-arabia/ 2026-04-07T07:53:15+00:00 https://qlinea.com/us/mfn_news/the-nomination-committees-proposals-to-q-lineas-annual-general-meeting-2026/ 2026-03-11T15:57:57+00:00 https://qlinea.com/us/financialevent/interim-report-q3-6/ 2026-03-04T15:51:52+00:00 https://qlinea.com/us/financialevent/interim-report-q2-8/ 2026-03-04T15:49:39+00:00 https://qlinea.com/us/financialevent/annual-general-meeting-2026/ 2026-03-04T15:48:51+00:00 https://qlinea.com/us/financialevent/interim-report-q1-6/ 2026-03-04T15:48:09+00:00 https://qlinea.com/us/financialevent/annual-report-2025/ 2026-03-04T15:46:36+00:00 https://qlinea.com/us/event-us/nacmid-2026-nashua/ 2026-02-13T15:16:41+00:00 https://qlinea.com/us/mfn_news/year-end-report-1-january-31-december-2025/ 2026-02-04T06:30:00+00:00 https://qlinea.com/us/event-us/amcli-2026-rimini/ 2026-01-30T10:07:31+00:00 https://qlinea.com/us/event-us/asm-microbe-2026-washington-d-c/ 2026-06-05T06:09:08+00:00 https://qlinea.com/us/event-us/nscmid-2026-copenhagen/ 2026-01-29T13:30:46+00:00 https://qlinea.com/us/event-us/whx-labs-2026-dubai/ 2026-01-29T13:16:50+00:00 https://qlinea.com/us/event-us/nycasm-2026-new-york-city/ 2026-01-27T15:14:38+00:00 https://qlinea.com/us/event-us/swacm-2026-houston/ 2026-01-29T13:09:56+00:00 https://qlinea.com/us/event-us/idweek-2026-washington-dc/ 2026-01-23T09:41:13+00:00 https://qlinea.com/us/event-us/adlm-2026-anaheim/ 2026-01-22T11:53:52+00:00 https://qlinea.com/us/event-us/mad-id-2026-orlando/ 2026-04-22T09:07:19+00:00 https://qlinea.com/us/event-us/escmid-global-2026-munich/ 2026-03-11T07:16:46+00:00 https://qlinea.com/us/mfn_news/large-independent-hospital-in-southeastern-united-states-adopts-astar/ 2026-01-20T07:47:20+00:00 https://qlinea.com/us/event-us/ewc-2026-new-orleans/ 2026-01-14T12:53:00+00:00 https://qlinea.com/us/event-us/scacm-2026-indianapolis/ 2026-03-31T14:45:09+00:00 https://qlinea.com/us/mfn_news/q-linea-announces-changes-in-us-commercial-leadership/ 2026-01-13T08:03:14+00:00 https://qlinea.com/us/mfn_news/q-linea-signs-first-distribution-agreement-in-south-asia/ 2026-01-07T08:03:56+00:00 https://qlinea.com/us/mfn_news/q-linea-ab-publ-omx-qlinea-today-announces-it-will-provide-astar-to-italian-users-of-the-accelerate-pheno-rapid-ast-system/ 2026-01-07T07:54:59+00:00 https://qlinea.com/us/mfn_news/q-linea-announces-first-two-us-hospital-systems-clinical-implementation-of-astar/ 2026-01-07T07:52:39+00:00 https://qlinea.com/us/event-us/ricai-2025/ 2025-12-17T09:11:20+00:00 https://qlinea.com/us/mfn_news/new-number-of-shares-and-votes-in-q-linea-ab-publ-5/ 2025-11-28T12:59:41+00:00 https://qlinea.com/us/mfn_news/q-linea-announces-new-organisation-and-changes-in-executive-leadership-team/ 2025-11-20T15:48:44+00:00 https://qlinea.com/us/mfn_news/q-linea-announces-fda-submission-for-expanded-claims-for-astar-bc-g-panel/ 2025-11-18T12:07:59+00:00 https://qlinea.com/us/mfn_news/q-linea-resolves-to-carry-out-a-directed-issue-of-shares-to-a-guarantor-in-connection-with-the-completed-preferential-rights-issue/ 2025-11-18T12:06:58+00:00 https://qlinea.com/us/mfn_news/q-linea-announces-outcome-of-rights-issue-3/ 2025-11-12T08:00:43+00:00 https://qlinea.com/us/mfn_news/q-linea-publishes-prospectus-in-connection-with-the-rights-issue-3/ 2025-10-22T14:21:26+00:00 https://qlinea.com/us/mfn_news/q-linea-announces-cost-efficiency-program-to-accelerate-sales-and-marketing-activities/ 2025-10-22T14:17:33+00:00 https://qlinea.com/us/mfn_news/bulletin-from-extraordinary-general-meeting-in-q-linea-ab-publ-3/ 2025-10-22T14:13:58+00:00 https://qlinea.com/us/mfn_news/interim-report-1-january-30-september-2025/ 2025-10-20T06:44:02+00:00 https://qlinea.com/us/mfn_news/stuart-gander-appointed-ceo-and-anders-ljunggren-appointed-deputy-ceo-of-q-linea-ab/ 2025-10-20T06:45:22+00:00 https://qlinea.com/us/mfn_news/us-trauma-center-signs-commercial-contract/ 2025-10-03T08:08:42+00:00 https://qlinea.com/us/mfn_news/notice-of-extraordinary-general-meeting-in-q-linea-ab-publ-4/ 2025-09-18T12:45:56+00:00 https://qlinea.com/us/mfn_news/q-linea-letter-from-the-ceo/ 2025-09-18T12:45:06+00:00 https://qlinea.com/us/mfn_news/q-linea-resolves-to-carry-out-a-rights-issue-of-approximately-sek-322-million-and-announces-terms/ 2025-09-18T12:41:23+00:00 https://qlinea.com/us/mfn_news/update-on-estar-tender-for-rapid-ast/ 2025-09-11T06:31:06+00:00 https://qlinea.com/us/mfn_news/q-linea-to-initiate-new-clinical-evaluations-of-astar-in-the-gcc-region/ 2025-09-05T10:44:09+00:00 https://qlinea.com/us/financialevent/year-end-report-8/ 2025-08-22T07:18:12+00:00 https://qlinea.com/us/event-us/imari-2025/ 2025-11-12T08:36:01+00:00 https://qlinea.com/us/event-us/eastern-pa-asm/ 2025-09-30T11:59:21+00:00 https://qlinea.com/us/event-us/nacmid-2025/ 2025-08-14T07:30:38+00:00 https://qlinea.com/us/mfn_news/interim-report-1-january-30-june-2025/ 2025-07-10T06:46:49+00:00 https://qlinea.com/us/mfn_news/correction-last-trading-day-before-reverse-share-split/ 2025-07-10T06:44:20+00:00 https://qlinea.com/us/mfn_news/bulletin-from-annual-general-meeting-in-q-linea-ab-publ-7/ 2025-06-27T06:44:20+00:00 https://qlinea.com/us/event-us/swacm-2025/ 2025-08-14T07:30:55+00:00 https://qlinea.com/us/event-us/idweek-2025/ 2025-08-19T06:46:40+00:00 https://qlinea.com/us/event-us/sidp-annual-meeting-2025/ 2025-08-14T07:27:14+00:00 https://qlinea.com/us/event-us/asm-microbe-2025-los-angeles/ 2025-06-23T06:24:10+00:00 https://qlinea.com/us/mfn_news/new-number-of-shares-and-votes-in-q-linea-ab-publ-3/ 2025-06-02T06:21:32+00:00 https://qlinea.com/us/mfn_news/q-lineas-board-of-directors-proposes-a-reverse-share-split-and-a-reduction-of-the-share-capital/ 2025-05-27T11:37:26+00:00 https://qlinea.com/us/mfn_news/notice-of-annual-general-meeting-in-q-linea-ab-publ-7/ 2025-05-23T08:31:20+00:00 https://qlinea.com/us/mfn_news/q-linea-announces-outcome-of-the-exercise-of-warrants-of-series-to1/ 2025-05-21T12:17:22+00:00 https://qlinea.com/us/mfn_news/today-15-may-2025-is-the-last-day-of-trading-in-warrants-series-to-1-in-q-linea/ 2025-05-15T07:19:59+00:00 https://qlinea.com/us/mfn_news/the-proposal-by-the-nomination-committee-of-q-linea-ab-publ-for-election-of-members-of-the-board-of-directors-6/ 2025-05-15T07:16:17+00:00 https://qlinea.com/us/presentations-us/presentation-redeye-theme-medtech-on-may-8-2025/ 2025-05-09T08:32:01+00:00 https://qlinea.com/us/event-us/stuart-gander-ceo-q-linea-presents-at-redeye-theme-medtech/ 2025-06-12T08:03:32+00:00 https://qlinea.com/us/mfn_news/q-linea-announces-determined-exercise-price-for-warrants-series-to-1-and-update-regarding-subscription-intentions/ 2025-05-02T13:48:50+00:00 https://qlinea.com/us/mfn_news/q-linea-announces-changes-in-executive-leadership-team-2/ 2025-04-28T14:35:20+00:00 https://qlinea.com/us/mfn_news/q-linea-publish-the-annual-report-for-2024/ 2025-04-25T17:05:59+00:00 https://qlinea.com/us/mfn_news/q-linea-announces-strong-support-of-the-to1-warrant-program-as-well-as-an-extension-of-existing-loan-from-large-shareholder/ 2025-04-16T08:23:06+00:00 https://qlinea.com/us/mfn_news/interim-report-1-january-31-march-2025/ 2025-04-14T06:58:47+00:00 https://qlinea.com/us/mfn_news/first-astar-evaluation-in-abu-dhabi-united-arab-emirates/ 2025-04-08T12:19:11+00:00 https://qlinea.com/us/mfn_news/changed-date-for-interim-report-3/ 2025-04-08T11:37:45+00:00 https://qlinea.com/us/mfn_news/q-linea-announces-the-sale-of-warrants-of-series-to-1-from-nexttobe-ab-to-investment-ab-oresund/ 2025-03-27T10:14:24+00:00 https://qlinea.com/us/mfn_news/q-linea-announces-tender-win-in-italy/ 2025-03-25T08:40:26+00:00 https://qlinea.com/us/presentations-us/biostock-interview-with-mario-gualano/ 2025-03-24T08:02:54+00:00 https://qlinea.com/us/mfn_news/additional-allocation-of-units-within-the-framework-of-recently-completed-issues/ 2025-03-19T13:46:18+00:00 https://qlinea.com/us/mfn_news/q-linea-anticipates-accelerating-astar-placements-through-2025-and-2026-driving-revenue-growth/ 2025-03-18T09:40:20+00:00 https://qlinea.com/us/mfn_news/master-service-agreement-signed-with-large-us-reference-laboratory/ 2025-03-10T08:33:19+00:00 https://qlinea.com/us/mfn_news/q-linea-announces-the-initiation-of-another-us-astar-evaluation/ 2025-03-07T10:23:11+00:00 https://qlinea.com/us/financialevent/extraordinary-general-meeting-in-q-linea-ab-publ/ 2025-03-05T09:12:58+00:00 https://qlinea.com/us/mfn_news/notice-of-extraordinary-general-meeting-in-q-linea-ab-publ-3/ 2025-03-03T13:47:07+00:00 https://qlinea.com/us/mfn_news/invitation-to-presentation-of-q-lineas-year-end-report-q4-2024-on-february-28-2025/ 2025-03-03T14:49:56+00:00 https://qlinea.com/us/mfn_news/new-number-of-shares-and-votes-in-q-linea-ab-publ/ 2025-03-03T15:06:30+00:00 https://qlinea.com/us/mfn_news/year-end-report-1-january-31-december-2024/ 2025-03-03T15:03:59+00:00 https://qlinea.com/us/mfn_news/q-linea-receives-contract-for-second-us-astar-instrument/ 2025-02-25T14:57:35+00:00 https://qlinea.com/us/mfn_news/q-lineas-rights-issue-is-registered-conversion-of-btu-into-shares-and-warrants/ 2025-02-13T14:20:38+00:00 https://qlinea.com/us/event-us/ammi-canada-cacmid/ 2025-06-12T08:03:48+00:00 https://qlinea.com/us/mfn_news/q-linea-shares-progress-on-roll-out-in-the-middle-east/ 2025-02-11T10:08:45+00:00 https://qlinea.com/us/mfn_news/q-linea-resolves-to-carry-out-a-directed-issue-of-units-to-guarantors-in-connection-with-the-completed-preferential-rights-issue/ 2025-02-10T16:12:07+00:00 https://qlinea.com/us/mfn_news/q-linea-awarded-first-public-tender-in-belgium/ 2025-02-05T09:25:11+00:00 https://qlinea.com/us/mfn_news/ghent-university-publishes-astar-study-results/ 2025-02-04T20:27:30+00:00 https://qlinea.com/us/mfn_news/q-linea-announces-outcome-of-rights-issue-2/ 2025-02-03T14:36:22+00:00 https://qlinea.com/us/mfn_news/vikas-gupta-pharmd-fidsa-joins-q-linea-as-senior-director-of-clinical-affairs/ 2025-01-31T12:56:07+00:00 https://qlinea.com/us/mfn_news/q-linea-announces-preliminary-outcome-of-the-rights-issue/ 2025-01-31T11:56:15+00:00 https://qlinea.com/us/mfn_news/continued-commercial-progress-with-us-reference-laboratory/ 2025-01-31T11:58:35+00:00 https://qlinea.com/us/event-us/adlm-2025-chicago/ 2025-08-11T14:37:51+00:00 https://qlinea.com/us/event-us/scacm-2025-spring-meeting/ 2025-06-12T08:04:12+00:00 https://qlinea.com/us/event-us/escmid-global/ 2025-06-11T14:42:52+00:00 https://qlinea.com/us/event-us/52-congresso-nazionale-amcli/ 2025-06-12T08:04:25+00:00 https://qlinea.com/us/mfn_news/first-us-customer-signs-commercial-contract/ 2025-01-14T08:06:54+00:00 https://qlinea.com/us/mfn_news/q-linea-resolves-on-the-terms-for-a-rights-issue-of-approximately-sek-225-million/ 2025-01-07T08:04:55+00:00 https://qlinea.com/us/mfn_news/bulletin-from-extraordinary-general-meeting-in-q-linea-ab-publ-2/ 2024-12-09T08:06:45+00:00 https://qlinea.com/us/mfn_news/notice-of-extraordinary-general-meeting-in-q-linea-ab-publ-2/ 2024-11-07T15:37:28+00:00 https://qlinea.com/us/mfn_news/interim-report-1-january-30-september-2024/ 2024-11-05T07:18:25+00:00 https://qlinea.com/us/mfn_news/q-linea-resolves-to-carry-out-a-rights-issue-of-approximately-sek-225-million-and-enters-into-an-agreement-for-a-bridge-loan-facility-of-approximately-sek-40-million/ 2024-11-05T07:26:13+00:00 https://qlinea.com/us/mfn_news/q-linea-to-participate-in-a-multi-site-public-tender-in-italy/ 2024-10-30T09:11:54+00:00 https://qlinea.com/us/mfn_news/astar-evaluation-begins-at-a-us-national-cancer-institute-designated-cancer-center/ 2024-10-29T08:33:07+00:00 https://qlinea.com/us/mfn_news/changed-date-for-interim-report-2/ 2024-10-29T08:37:02+00:00 https://qlinea.com/us/mfn_news/q-linea-receives-request-for-a-3-year-contract-at-prominent-hospital-in-milan-italy/ 2024-10-25T10:28:42+00:00 https://qlinea.com/us/mfn_news/two-uk-commercial-evaluations-closing-successfully/ 2024-10-24T13:46:34+00:00 https://qlinea.com/us/mfn_news/q-linea-announces-the-initiation-of-a-door-mat-study-at-a-large-us-academic-medical-center/ 2024-10-24T10:12:57+00:00 https://qlinea.com/us/mfn_news/invitation-to-presentation-of-q-lineas-interim-report-q3-2024-on-october-31-2024/ 2024-10-24T10:19:13+00:00 https://qlinea.com/us/mfn_news/us-reference-laboratory-completes-astar-evaluation/ 2024-10-21T07:16:57+00:00 https://qlinea.com/us/mfn_news/q-linea-further-expands-us-commercial-team/ 2024-10-08T07:02:45+00:00 https://qlinea.com/us/mfn_news/q-linea-announces-changes-in-executive-leadership-team/ 2024-10-08T07:09:55+00:00 https://qlinea.com/us/mfn_news/q-linea-enters-the-middle-east-region-through-partnership-with-amico-group/ 2024-09-27T10:52:31+00:00 https://qlinea.com/us/presentations-us/recorded-webinar-clinical-evaluation-of-an-fda-cleared-high-throughput-rapid-antibiotic-susceptibility-testing-system/ 2024-10-29T08:49:57+00:00 https://qlinea.com/us/mfn_news/two-leading-us-microbiology-labs-present-interim-evaluation-data-on-webinar/ 2024-09-26T15:37:00+00:00 https://qlinea.com/us/event-us/scacm-fall-meeting-michigan/ 2025-01-22T07:18:53+00:00 https://qlinea.com/us/event-us/nacmid-2024-conference/ 2025-01-22T07:19:52+00:00 https://qlinea.com/us/mfn_news/q-linea-enters-into-distribution-agreement-with-s-c-mecro-system-s-r-l/ 2024-09-11T06:55:18+00:00 https://qlinea.com/us/mfn_news/cms-grants-new-technology-add-on-payment-ntap-for-astar/ 2024-08-28T14:39:17+00:00 https://qlinea.com/us/mfn_news/astar-evaluation-data-presented-at-swacm-by-leading-us-health-system-medical-center/ 2024-08-28T07:30:11+00:00 https://qlinea.com/us/event-us/webinar-clinical-evaluation-of-an-fda-cleared-high-throughput-rapid-antibiotic-susceptibility-testing-system/ 2025-01-22T07:21:01+00:00 https://qlinea.com/us/event-us/swacm-2024-annual-meeting/ 2025-01-22T07:21:20+00:00 https://qlinea.com/us/mfn_news/interim-report-1-january-30-june-2024/ 2024-07-11T06:23:09+00:00 https://qlinea.com/us/financialevent/interim-report-q3-5/ 2025-08-22T07:00:27+00:00 https://qlinea.com/us/financialevent/interim-report-q2-7/ 2024-07-09T11:38:05+00:00 https://qlinea.com/us/financialevent/annual-general-meeting-2025/ 2025-02-18T14:28:43+00:00 https://qlinea.com/us/financialevent/interim-report-q1-5/ 2025-04-08T06:35:09+00:00 https://qlinea.com/us/financialevent/annual-report-2024/ 2025-03-10T11:39:01+00:00 https://qlinea.com/us/financialevent/year-end-report-7/ 2025-01-20T08:09:31+00:00 https://qlinea.com/us/presentations-us/q-linea-q1-report-2024/ 2024-07-09T11:41:48+00:00 https://qlinea.com/us/event-us/idweek-2024/ 2025-01-22T07:21:40+00:00 https://qlinea.com/us/event-us/adlm-2024/ 2025-01-22T07:21:56+00:00 https://qlinea.com/us/presentations-us/life-science-day-2024/ 2025-05-09T08:13:46+00:00 https://qlinea.com/us/presentations-us/redeye-theme-commercialization-in-life-science-on-march-20-2024/ 2024-03-21T12:56:38+00:00 https://qlinea.com/us/presentations-us/carnegie-healthcare-seminar-2024-mars-6/ 2024-03-18T13:48:26+00:00 https://qlinea.com/us/testimonials/the-astar-system-represents-an-exciting-innovative-platform/ 2023-10-10T09:31:27+00:00 https://qlinea.com/us/event-us/asm-2024/ 2025-01-22T07:22:14+00:00 https://qlinea.com/us/event-us/eccmid-2024/ 2025-01-22T07:22:34+00:00 https://qlinea.com/us/event-us/nscmid-2023-2/ 2024-03-18T14:53:29+00:00 https://qlinea.com/us/event-us/id-week-2023/ 2024-03-18T14:53:47+00:00 https://qlinea.com/us/financialevent/interim-report-q3-4/ 2024-10-28T09:41:06+00:00 https://qlinea.com/us/financialevent/interim-report-q2-6/ 2023-08-28T12:46:26+00:00 https://qlinea.com/us/financialevent/annual-general-meeting-2024/ 2024-05-15T08:30:50+00:00 https://qlinea.com/us/financialevent/interim-report-q1-4/ 2024-05-27T10:24:24+00:00 https://qlinea.com/us/financialevent/annual-report-2023/ 2023-08-28T12:43:24+00:00 https://qlinea.com/us/financialevent/year-end-report-6/ 2024-01-15T07:12:54+00:00 https://qlinea.com/us/event-us/presentation-q2-2023-results/ 2023-07-02T13:43:20+00:00 https://qlinea.com/us/financialevent/extra-annual-general-meeting-2023/ 2023-06-08T14:48:30+00:00 https://qlinea.com/us/event-us/redeye-growth-day-2023-interview-with-ceo-jonas-jarvius/ 2023-06-05T09:58:53+00:00 https://qlinea.com/us/event-us/asm-microbe-2023/ 2025-01-22T07:23:04+00:00 https://qlinea.com/us/event-us/the-infection-week-microbiological-spring-meeting/ 2023-05-15T10:19:28+00:00 https://qlinea.com/us/event-us/presentation-readeye-medtech-event-may-10-2023/ 2023-05-11T15:28:54+00:00 https://qlinea.com/us/event-us/presentation-interim-report-january-march-2023/ 2023-05-04T15:46:41+00:00 https://qlinea.com/us/event-us/q-linea-presents-at-life-science-investor-konference-in-copenhagen-new-time/ 2023-04-12T14:36:36+00:00 https://qlinea.com/us/event-us/presentation-stockholm-corporate-finance-15th-life-science-capital-market-days/ 2023-03-15T15:27:38+00:00 https://qlinea.com/us/event-us/eccmid-2023/ 2025-06-12T08:05:22+00:00 https://qlinea.com/us/presentations-us/redeye-life-science-day-2022-interview-with-ceo-jonas-jarvius/ 2022-12-07T13:37:03+00:00 https://qlinea.com/us/presentations-us/trading-direkt-healthcare-interview-november-2022/ 2022-11-10T12:30:23+00:00 https://qlinea.com/us/event-us/framtidens-halsa-sjukvard-2023/ 2022-11-03T09:10:14+00:00 https://qlinea.com/us/financialevent/interim-report-q3-3/ 2022-06-02T08:37:04+00:00 https://qlinea.com/us/financialevent/interim-report-q2-5/ 2022-06-02T08:36:38+00:00 https://qlinea.com/us/financialevent/annual-general-meeting-2022/ 2022-06-02T08:35:54+00:00 https://qlinea.com/us/financialevent/interim-report-q1-3/ 2022-06-02T08:35:11+00:00 https://qlinea.com/us/financialevent/annual-report-2022/ 2022-06-02T08:34:35+00:00 https://qlinea.com/us/financialevent/year-end-report-5/ 2022-06-02T08:31:45+00:00 https://qlinea.com/us/event-us/redeye-medtech-diagnostics-seminar-may-11-2022/ 2022-04-26T11:03:59+00:00 https://qlinea.com/us/event-us/asm-2022/ 2022-03-31T09:49:58+00:00 https://qlinea.com/us/event-us/eccmid-2022/ 2022-03-31T09:10:47+00:00 https://qlinea.com/us/event-us/abgsc-investor-day-7-december-2021/ 2021-12-13T10:03:31+00:00 https://qlinea.com/us/testimonials/save-time-and-lives-with-improved-diagnostics/ 2021-08-16T11:51:34+00:00 https://qlinea.com/us/financialevent/interim-report-q3-2/ 2021-06-17T09:07:15+00:00 https://qlinea.com/us/financialevent/interim-report-q2-4/ 2021-06-17T09:06:32+00:00 https://qlinea.com/us/financialevent/annual-general-meeting-4/ 2021-06-17T09:05:27+00:00 https://qlinea.com/us/financialevent/interim-report-q1-2/ 2021-06-17T09:01:22+00:00 https://qlinea.com/us/financialevent/year-end-report-4/ 2021-06-17T08:57:30+00:00 https://qlinea.com/us/financialevent/annual-report-2021/ 2021-06-17T08:56:08+00:00 https://qlinea.com/us/presentations-us/vd-presentation-till-arsstamma-2021-05-25/ 2021-05-11T08:40:27+00:00 https://qlinea.com/us/event-us/redeye-theme-medtech-diagnostics-may-5th/ 2021-05-07T07:35:46+00:00 https://qlinea.com/us/event-us/ou-life-science-investor-conference/ 2021-05-07T07:20:05+00:00 https://qlinea.com/us/testimonials/ast-results-deeply-inform-calculated-antibiotic-treatment/ 2021-01-07T13:25:29+00:00 https://qlinea.com/us/testimonials/rapid-information-on-the-antimicrobial-susceptibility-profile-is-crucial/ 2021-01-07T13:24:23+00:00 https://qlinea.com/us/testimonials/targeted-antimicrobial-treatment-is-considered-the-only-sustainable-strategy/ 2021-01-07T13:23:48+00:00 https://qlinea.com/us/testimonials/the-earlier-we-can-give-targeted-treatment-the-better/ 2021-01-07T13:23:11+00:00 https://qlinea.com/us/testimonials/you-will-be-much-faster-in-adjusting-the-treatment/ 2021-01-05T11:59:47+00:00 https://qlinea.com/us/testimonials/a-huge-advantage/ 2021-01-05T11:58:35+00:00 https://qlinea.com/us/financialevent/interim-report-q3/ 2020-11-11T12:58:57+00:00 https://qlinea.com/us/financialevent/interim-report-q2-3/ 2020-11-11T12:58:15+00:00 https://qlinea.com/us/financialevent/annual-general-meeting-3/ 2020-11-11T12:56:42+00:00 https://qlinea.com/us/financialevent/interim-report-q1/ 2020-11-11T12:56:04+00:00 https://qlinea.com/us/financialevent/annual-report-2020/ 2020-11-11T12:54:56+00:00 https://qlinea.com/us/financialevent/year-end-report-3/ 2020-11-11T12:53:57+00:00 https://qlinea.com/us/event-us/redeye-life-science-day/ 2020-11-02T08:56:30+00:00 https://qlinea.com/us/financialevent/redeye-life-science-day/ 2020-11-02T08:50:42+00:00 https://qlinea.com/us/financialevent/redeye-diagnostics-2020/ 2020-10-26T15:54:15+00:00 https://qlinea.com/us/event-us/redeye-diagnostics-2020/ 2020-10-26T15:23:09+00:00 https://qlinea.com/us/event-us/pareto-securities-11th-annual-healthcare-conference/ 2020-08-31T13:51:50+00:00 https://qlinea.com/us/financialevent/pareto-securities-11th-annual-healthcare-conference/ 2020-08-31T13:45:13+00:00 https://qlinea.com/us/financialevent/annual-general-meeting-2/ 2020-06-11T09:14:42+00:00 https://qlinea.com/us/financialevent/interim-report-quarter-1-2/ 2020-06-11T09:13:46+00:00 https://qlinea.com/us/financialevent/annual-report-2019/ 2020-06-11T09:13:11+00:00 https://qlinea.com/us/financialevent/year-end-report-2/ 2020-06-11T09:09:12+00:00 https://qlinea.com/us/financialevent/interim-report-quarter-3/ 2020-06-11T09:03:36+00:00 https://qlinea.com/us/financialevent/interim-report-quarter-2/ 2020-06-11T09:02:27+00:00 https://qlinea.com/us/financialevent/annual-general-meeting/ 2020-06-11T08:56:47+00:00 https://qlinea.com/us/financialevent/interim-report-quarter-1/ 2020-06-11T08:52:16+00:00 https://qlinea.com/us/financialevent/year-end-report/ 2020-06-11T08:48:59+00:00 https://qlinea.com/us/event-us/webinar-june-5th-2020/ 2020-06-09T06:46:23+00:00 https://qlinea.com/us/financialevent/interim-report-q2-2/ 2020-06-05T08:21:50+00:00 https://qlinea.com/us/financialevent/interim-report-q2/ 2020-06-05T08:19:46+00:00 https://qlinea.com/us/event-us/redeye-growth-day-2020-06-02/ 2020-05-28T09:04:23+00:00 https://qlinea.com/us/presentations-us/jonas-jarvius-ceo-president-presents-at-redeye-march-12-2020/ 2020-03-18T08:53:50+00:00 https://qlinea.com/us/presentations-us/interview-with-ceo-jonas-jarvius-2018-12-07/ 2020-02-17T08:06:26+00:00 https://qlinea.com/us/presentations-us/interview-with-ceo-jonas-jarvius-2020-02-13/ 2020-02-14T14:51:20+00:00 https://qlinea.com/us/event-us/kempen-life-sciences-conference/ 2020-02-04T08:02:32+00:00 https://qlinea.com/us/event-us/stockholm-corporate-finance-12th-life-science-seminar/ 2020-02-04T07:59:36+00:00 https://qlinea.com/us/event-us/life-science-investorkonference-q1-2020/ 2020-01-28T07:46:25+00:00 https://qlinea.com/us/event-us/annual-general-meeting-2020/ 2020-01-09T10:27:10+00:00 https://qlinea.com/us/event-us/carnegie-nordic-healthcare-seminar-stockholm/ 2020-01-09T10:26:42+00:00 https://qlinea.com/us/event-us/year-end-report-january-to-december-2019/ 2020-01-09T10:05:52+00:00 https://qlinea.com/us/event-us/annual-report-2019/ 2020-01-09T09:57:26+00:00 https://qlinea.com/us/presentations-us/in-swedish-interview-with-ceo-jonas-jarvius-redeye-after-work-november-8th-2019/ 2019-11-07T09:28:40+00:00 https://qlinea.com/us/presentations-us/jonas-jarvius-ceo-presentation-redeye-after-work-november-8th-2019/ 2019-11-07T09:25:56+00:00